OX40L was blocked just during the extra immunization by administering 250g of RM134L intraperitoneally on times 1 and 0 in accordance with rechallenge. as an
Structure-Based Design of mTORC1 Inhibitors in Cancer Therapy
mTORC1 inhibitor
mTORC1 inhibitor
OX40L was blocked just during the extra immunization by administering 250g of RM134L intraperitoneally on times 1 and 0 in accordance with rechallenge. as an